Evaluación positiva de medicamentos: julio, septiembre y octubre de 2022 / Positive assessment of drugs: July, September and October of 2022
Sanid. mil
; 78(4): 261-267, Oct-Dic. 2022.
Article
in Spanish
| IBECS
| ID: ibc-220568
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
RESUMEN
Se reseñan los medicamentos evaluados y con dictamen positivo por comisión de expertos de la Agencia Europea del Medicamento, hechos públicos en julio, septiembre y octubre de 2022 y considerados de mayor interés para el profesional sanitario. Se trata de opiniones técnicas positivas que son previas a la autorización y puesta en el mercado del medicamento.(AU)
ABSTRACT
The drugs assessed by the European Medicines Agency made public in July, September and October of 2022, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.(AU)
Abaloparatida (Eladynos®); Espesolimab (Spevigo®); Faricimab (Vabysmo®); Fosdenopterina (Nulibry®); Gozetotida (Locametz®); Loncastuximab tesirina (Zynlonta®); Maralixibat (Livmarli®); Maribavir (Livtencity®); Mitapivat (Pyrukynd®); Nirsevibab (Beyforuts®); Nivolumab/Relatlimab (Opdualag®); Sutimlimab (Enjaymo®); Tabelecleucel (Ebvallo®); Teclistamab (Tecvayli®); Tezepelumab (Tezspire®); Tirzepatida (Mounjaro®); Vacuna tetravalente contra el dengue (Qdenga®); Vipivotida tetraxetan lutecio (177LU) (Pluvicto®); Voclosporina (Lupkynis®); Vutrisiran (Amvuttra®); Abaloparatida (Eladynos®); Espesolimab (Spevigo®); Faricimab (Vabysmo®); Fosdenopterina (Nulibry®); Gozetotida (Locametz®); Loncastuximab tesirina (Zynlonta®); Maralixibat (Livmarli®); Maribavir (Livtencity®); Mitapivat (Pyrukynd®); Nirsevibab (Beyforuts®); Nivolumab/Relatlimab (Opdualag®); Sutimlimab (Enjaymo®); Tabelecleucel (Ebvallo®); Teclistamab (Tecvayli®); Tezepelumab (Tezspire®); Tirzepatida (Mounjaro®); Vacuna tetravalente contra el dengue (Qdenga ®); Vipivotida tetraxetan lutecio (177LU) (Pluvicto®); Voclosporina (Lupkynis®); Vutrisiran (Amvuttra ®)
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Pharmaceutical Preparations
/
Pharmaceutical Trade
/
Legislation, Drug
Limits:
Humans
Language:
Spanish
Journal:
Sanid. mil
Year:
2022
Document type:
Article
Institution/Affiliation country:
Hospital Central de la Defensa Gómez Ulla/España
